Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Jonathan Mark Petrash

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-OP General Operations

    Collapse Research 
    Collapse research activities and funding
    R01EY028147     (PETRASH, JONATHAN MARK)Sep 1, 2017 - Jun 30, 2022
    NIH
    Molecular Signaling in Cataracts
    Role: Principal Investigator
    R01EY021498     (PETRASH, JONATHAN MARK)Sep 30, 2011 - Aug 31, 2017
    NIH
    Novel Therapeutics Against Diabetic Eye Disease
    Role: Principal Investigator
    T35EY021455     (PETRASH, JONATHAN MARK)Jan 1, 2011 - Dec 31, 2015
    NIH
    Vision Research Training Program
    Role: Principal Investigator
    RC1EY020361     (PETRASH, JONATHAN MARK)Sep 30, 2009 - Sep 29, 2011
    NIH
    Development of Small Heat Shock Proteins as Therapeutic Agents in the Eye
    Role: Principal Investigator
    R01EY013897     (PETRASH, JONATHAN MARK)May 1, 2002 - Apr 30, 2008
    NIH
    Molecular Interactions of Crystallins in the Eye
    Role: Principal Investigator
    R55EY005856     (PETRASH, JONATHAN MARK)Jul 16, 1988 - Mar 31, 1992
    NIH
    MOLECULAR BIOLOGY OF ALDOSE REDUCTASE AND CATARACT
    Role: Principal Investigator
    R01EY005856     (PETRASH, JONATHAN MARK)Dec 1, 1984 - Mar 31, 2017
    NIH
    Aldose Reductase and Diabetic Eye Disease
    Role: Principal Investigator
    R23EY005856     (PETRASH, JONATHAN MARK)Dec 1, 1984 - May 31, 1988
    NIH
    MOLECULAR STUDIES OF ALDOSE REDUCTASE AND CATARACT
    Role: Principal Investigator
    R13EY002143     (PETRASH, JONATHAN MARK)Dec 1, 1979 - Nov 30, 2023
    NIH
    Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).
    Role: Principal Investigator
    P30EY002687     (BASSNETT, STEVEN)Dec 1, 1978 - Aug 31, 2025
    NIH
    Core Grant for Vision Research
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kalahasti KK, Kumar CU, Nagaraju M, Petrash JM, Reddy SS, Reddy GB. Mitigation of lens opacification by a functional food in a diabetic rodent model. Chem Biol Interact. 2024 Feb 25; 390:110889. PMID: 38272248.
      View in: PubMed
    2. Kant R, Mishra N, Kandhari K, Saba L, Michel C, Reisdorph R, Tewari-Singh N, Pantcheva MB, Petrash JM, Agarwal C, Agarwal R. Dexamethasone targets actin cytoskeleton signaling and inflammatory mediators to reverse sulfur mustard-induced toxicity in rabbit corneas. Toxicol Appl Pharmacol. 2024 02; 483:116834. PMID: 38266871.
      View in: PubMed
    3. Mishra N, Kant R, Kandhari K, Tewari-Singh N, Anantharam P, Croutch CR, Pantcheva MB, Petrash JM, Araj H, Agarwal C, Agarwal R. Establishing a Dexamethasone Treatment Regimen To Alleviate Sulfur Mustard-Induced Corneal Injuries in a Rabbit Model. J Pharmacol Exp Ther. 2024 01 17; 388(2):469-483. PMID: 37316330.
      View in: PubMed
    4. Mishra N, Kant R, Kandhari K, Ammar DA, Tewari-Singh N, Pantcheva MB, Petrash JM, Agarwal C, Agarwal R. Nitrogen Mustard-Induced Ex Vivo Human Cornea Injury Model and Therapeutic Intervention by Dexamethasone. J Pharmacol Exp Ther. 2024 01 17; 388(2):484-494. PMID: 37474260.
      View in: PubMed
    5. Mishra N, Kant R, Goswami DG, Petrash JM, Agarwal C, Tewari-Singh N, Agarwal R. Metabolomics for identifying pathways involved in vesicating agent lewisite-induced corneal injury. Exp Eye Res. 2023 11; 236:109672. PMID: 37797797.
      View in: PubMed
    6. Ebenezar OO, Roney A, Goswami DG, Petrash JM, Sledge D, Kom?romy AM, Liby KT, Tewari-Singh N. Ocular injury progression and cornea histopathology from chloropicrin vapor exposure: Relevant clinical biomarkers in mice. Exp Eye Res. 2023 05; 230:109440. PMID: 36933694.
      View in: PubMed
    7. Upadhyay AK, Mueller NH, Petrash JM, Kompella UB. Nano-assemblies enhance chaperone activity, stability, and delivery of alpha B-crystallin-D3 (aB-D3). J Control Release. 2022 Dec; 352:411-421. PMID: 36272662.
      View in: PubMed
    8. Petrash JM, Vasiliou V. Editorial for carbonyl metabolism. Chem Biol Interact. 2022 08 25; 363:110006. PMID: 35662544.
      View in: PubMed
    9. Goswami DG, Mishra N, Kant R, Agarwal C, Ammar DA, Petrash JM, Tewari-Singh N, Agarwal R. Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model. Toxicol Appl Pharmacol. 2022 02 15; 437:115904. PMID: 35108561.
      View in: PubMed
    10. Pedler MG, Petrash JM, Subramanian PS. Prostaglandin analog effects on cerebrospinal fluid reabsorption via nasal mucosa. PLoS One. 2021; 16(12):e0248545. PMID: 34971554.
      View in: PubMed
    11. Fichtner JE, Patnaik J, Christopher KL, Petrash JM. Cataract inhibitors: Present needs and future challenges. Chem Biol Interact. 2021 Nov 01; 349:109679. PMID: 34600869.
      View in: PubMed
    12. Gautam D, Pedler MG, Nair DP, Petrash JM. Nanogel-Facilitated In-Situ Delivery of a Cataract Inhibitor. Biomolecules. 2021 08 04; 11(8). PMID: 34439816.
      View in: PubMed
    13. Patnaik JL, Christopher KL, Pedler MG, Shieh B, Petrash CC, Wagner BD, Mandava N, Lynch AM, Palestine AG, Petrash JM. The Protective Effect of Metformin Use on Early Nd:YAG Laser Capsulotomy. Invest Ophthalmol Vis Sci. 2021 08 02; 62(10):24. PMID: 34415985.
      View in: PubMed
    14. Petrash JM, Shieh B, Ammar DA, Pedler MG, Orlicky DJ. Diabetes-Independent Retinal Phenotypes in an Aldose Reductase Transgenic Mouse Model. Metabolites. 2021 Jul 10; 11(7). PMID: 34357344.
      View in: PubMed
    15. Hupy ML, Pedler MG, Shieh B, Wang D, Wang XJ, Petrash JM. Suppression of epithelial to mesenchymal transition markers in mouse lens by a Smad7-based recombinant protein. Chem Biol Interact. 2021 Aug 01; 344:109495. PMID: 33961834.
      View in: PubMed
    16. Goswami DG, Kant R, Ammar DA, Kumar D, Enzenauer RW, Petrash JM, Tewari-Singh N, Agarwal R. Acute corneal injury in rabbits following nitrogen mustard ocular exposure. Exp Mol Pathol. 2019 10; 110:104275. PMID: 31233733.
      View in: PubMed
    17. Zukin LM, Pedler MG, Chyung K, Seiwald S, Lenhart P, Shieh B, Petrash JM. Aldose reductase inhibition enhances lens regeneration in mice. Chem Biol Interact. 2019 Jul 01; 307:58-62. PMID: 31026421.
      View in: PubMed
    18. Petrash JM. Editorial. Chem Biol Interact. 2019 May 25; 305:11. PMID: 30898601.
      View in: PubMed
    19. Chang KC, Shieh B, Petrash JM. Role of aldose reductase in diabetes-induced retinal microglia activation. Chem Biol Interact. 2019 Apr 01; 302:46-52. PMID: 30682331.
      View in: PubMed
    20. Zhang C, Lai MB, Pedler MG, Johnson V, Adams RH, Petrash JM, Chen Z, Junge HJ. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature. Arterioscler Thromb Vasc Biol. 2018 11; 38(11):2691-2705. PMID: 30354230.
      View in: PubMed
    21. Zukin LM, Pedler MG, Groman-Lupa S, Pantcheva M, Ammar DA, Petrash JM. Aldose Reductase Inhibition Prevents Development of Posterior Capsular Opacification in an In Vivo Model of Cataract Surgery. Invest Ophthalmol Vis Sci. 2018 07 02; 59(8):3591-3598. PMID: 30025084.
      View in: PubMed
    22. Kalita D, Holm DG, LaBarbera DV, Petrash JM, Jayanty SS. Inhibition of a-glucosidase, a-amylase, and aldose reductase by potato polyphenolic compounds. PLoS One. 2018; 13(1):e0191025. PMID: 29370193.
      View in: PubMed
    23. Chang KC, Petrash JM. Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease. Adv Exp Med Biol. 2018; 1032:173-202. PMID: 30362099.
      View in: PubMed
    24. Kennedy JB, Larochelle MB, Pedler MG, Petrash JM, Enzenauer RW. The effect of amniotic membrane grafting on healing and wound strength after strabismus surgery in a rabbit model. J AAPOS. 2018 02; 22(1):22-26.e1. PMID: 29225157.
      View in: PubMed
    25. Tewari-Singh N, Goswami DG, Kant R, Ammar DA, Kumar D, Enzenauer RW, Casillas RP, Croutch CR, Petrash JM, Agarwal R. Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure. Toxicol Sci. 2017 Dec 01; 160(2):420-428. PMID: 28973427.
      View in: PubMed
    26. Chang KC, Shieh B, Petrash JM. Influence of aldose reductase on epithelial-to-mesenchymal transition signaling in lens epithelial cells. Chem Biol Interact. 2017 Oct 01; 276:149-154. PMID: 28137510.
      View in: PubMed
    27. Diego JL, Bidikov L, Pedler MG, Kennedy JB, Quiroz-Mercado H, Gregory DG, Petrash JM, McCourt EA. Effect of human milk as a treatment for dry eye syndrome in a mouse model. Mol Vis. 2016; 22:1095-1102. PMID: 27667918.
      View in: PubMed
    28. Chang KC, Li L, Sanborn TM, Shieh B, Lenhart P, Ammar D, LaBarbera DV, Petrash JM. Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract. J Nat Prod. 2016 05 27; 79(5):1439-44. PMID: 27140653.
      View in: PubMed
    29. Chang KC, Shieh B, Petrash JM. Aldose reductase mediates retinal microglia activation. Biochem Biophys Res Commun. 2016 Apr 29; 473(2):565-71. PMID: 27033597.
      View in: PubMed
    30. Tewari-Singh N, Croutch CR, Tuttle R, Goswami DG, Kant R, Peters E, Culley T, Ammar DA, Enzenauer RW, Petrash JM, Casillas RP, Agarwal R. Clinical progression of ocular injury following arsenical vesicant lewisite exposure. Cutan Ocul Toxicol. 2016 Dec; 35(4):319-28. PMID: 27002633.
      View in: PubMed
    31. Goswami DG, Tewari-Singh N, Dhar D, Kumar D, Agarwal C, Ammar DA, Kant R, Enzenauer RW, Petrash JM, Agarwal R. Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization. Cornea. 2016 Feb; 35(2):257-66. PMID: 26555588.
      View in: PubMed
    32. Mueller NH, Fogueri U, Pedler MG, Montana K, Petrash JM, Ammar DA. Impact of Subunit Composition on the Uptake of a-Crystallin by Lens and Retina. PLoS One. 2015; 10(9):e0137659. PMID: 26355842.
      View in: PubMed
    33. Chang KC, Petrash JM. Aldose Reductase Mediates Transforming Growth Factor ?2 (TGF-?2)-Induced Migration and Epithelial-To-Mesenchymal Transition of Lens-Derived Epithelial Cells. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4198-210. PMID: 26132779.
      View in: PubMed
    34. Nagaraj RH, Nahomi RB, Mueller NH, Raghavan CT, Ammar DA, Petrash JM. Therapeutic potential of a-crystallin. Biochim Biophys Acta. 2016 Jan; 1860(1 Pt B):252-7. PMID: 25840354.
      View in: PubMed
    35. Snow A, Shieh B, Chang KC, Pal A, Lenhart P, Ammar D, Ruzycki P, Palla S, Reddy GB, Petrash JM. Aldose reductase expression as a risk factor for cataract. Chem Biol Interact. 2015 Jun 05; 234:247-53. PMID: 25541468.
      View in: PubMed
    36. Chang KC, Snow A, LaBarbera DV, Petrash JM. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells. Chem Biol Interact. 2015 Jun 05; 234:254-60. PMID: 25451566.
      View in: PubMed
    37. Lanaspa MA, Ishimoto T, Cicerchi C, Tamura Y, Roncal-Jimenez CA, Chen W, Tanabe K, Andres-Hernando A, Orlicky DJ, Finol E, Inaba S, Li N, Rivard CJ, Kosugi T, Sanchez-Lozada LG, Petrash JM, Sautin YY, Ejaz AA, Kitagawa W, Garcia GE, Bonthron DT, Asipu A, Diggle CP, Rodriguez-Iturbe B, Nakagawa T, Johnson RJ. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J Am Soc Nephrol. 2014 Nov; 25(11):2526-38. PMID: 24876114.
      View in: PubMed
    38. Lee CA, Li G, Patel MD, Petrash JM, Benetz BA, Veenstra A, Amengual J, von Lintig J, Burant CJ, Tang J, Kern TS. Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Invest Ophthalmol Vis Sci. 2014 May 02; 55(5):2904-10. PMID: 23920367.
      View in: PubMed
    39. Chang KC, Ponder J, Labarbera DV, Petrash JM. Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia. Invest Ophthalmol Vis Sci. 2014 May 02; 55(5):2853-61. PMID: 24677107.
      View in: PubMed
    40. Li L, Chang KC, Zhou Y, Shieh B, Ponder J, Abraham AD, Ali H, Snow A, Petrash JM, LaBarbera DV. Design of an amide N-glycoside derivative of ?-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. J Med Chem. 2014 Jan 09; 57(1):71-7. PMID: 24341381.
      View in: PubMed
    41. Petrash JM. Aging and age-related diseases of the ocular lens and vitreous body. Invest Ophthalmol Vis Sci. 2013 Dec 13; 54(14):ORSF54-9. PMID: 24335070.
      View in: PubMed
    42. Christopher KL, Pedler MG, Shieh B, Ammar DA, Petrash JM, Mueller NH. Alpha-crystallin-mediated protection of lens cells against heat and oxidative stress-induced cell death. Biochim Biophys Acta. 2014 Feb; 1843(2):309-15. PMID: 24275510.
      View in: PubMed
    43. Yandrapu SK, Upadhyay AK, Petrash JM, Kompella UB. Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. Mol Pharm. 2013 Dec 02; 10(12):4676-86. PMID: 24131101.
      View in: PubMed
    44. Tang J, Du Y, Petrash JM, Sheibani N, Kern TS. Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation. PLoS One. 2013; 8(4):e62081. PMID: 23614016.
      View in: PubMed
    45. ?nzs?ly A, Mark? K, T?bi T, Sz?ko ?, Zelk? R, T?th M, Petrash JM, M?tyus P, N?meth J. Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model. J Neural Transm (Vienna). 2013 Jun; 120(6):969-75. PMID: 23397320.
      View in: PubMed
    46. Mueller NH, Ammar DA, Petrash JM. Cell penetration peptides for enhanced entry of aB-crystallin into lens cells. Invest Ophthalmol Vis Sci. 2013 Jan 02; 54(1):2-8. PMID: 23150610.
      View in: PubMed
    47. Lanaspa MA, Ishimoto T, Li N, Cicerchi C, Orlicky DJ, Ruzycki P, Ruzicky P, Rivard C, Inaba S, Roncal-Jimenez CA, Bales ES, Diggle CP, Asipu A, Petrash JM, Kosugi T, Maruyama S, Sanchez-Lozada LG, McManaman JL, Bonthron DT, Sautin YY, Johnson RJ. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun. 2013; 4:2434. PMID: 24022321.
      View in: PubMed
    48. Chang KC, Laffin B, Ponder J, Enzs?ly A, N?meth J, LaBarbera DV, Petrash JM. Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues. Chem Biol Interact. 2013 Feb 25; 202(1-3):283-7. PMID: 23247009.
      View in: PubMed
    49. Samuels IS, Lee CA, Petrash JM, Peachey NS, Kern TS. Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease. Vis Neurosci. 2012 Nov; 29(6):267-74. PMID: 23101909.
      View in: PubMed
    50. Rao VR, Muthenna P, Shankaraiah G, Akileshwari C, Babu KH, Suresh G, Babu KS, Chandra Kumar RS, Prasad KR, Yadav PA, Petrash JM, Reddy GB, Rao JM. Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs). Eur J Med Chem. 2012 Nov; 57:344-61. PMID: 23124161.
      View in: PubMed
    51. Tewari-Singh N, Jain AK, Inturi S, Ammar DA, Agarwal C, Tyagi P, Kompella UB, Enzenauer RW, Petrash JM, Agarwal R. Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries. Toxicol Appl Pharmacol. 2012 Oct 01; 264(1):23-31. PMID: 22841772.
      View in: PubMed
    52. Akileshwari C, Muthenna P, Nastasijevic B, Joksic G, Petrash JM, Reddy GB. Inhibition of aldose reductase by Gentiana lutea extracts. Exp Diabetes Res. 2012; 2012:147965. PMID: 22844269.
      View in: PubMed
    53. Laffin B, Petrash JM. Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers. Front Pharmacol. 2012; 3:104. PMID: 22685431.
      View in: PubMed
    54. Puppala M, Ponder J, Suryanarayana P, Reddy GB, Petrash JM, LaBarbera DV. The isolation and characterization of ?-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. PLoS One. 2012; 7(4):e31399. PMID: 22485126.
      View in: PubMed
    55. Validandi V, Reddy VS, Srinivas PN, Mueller NH, Bhagyalaxmi SG, Padma T, Petrash JM, Reddy GB. Temperature-dependent structural and functional properties of a mutant (F71L) aA-crystallin: molecular basis for early onset of age-related cataract. FEBS Lett. 2011 Dec 15; 585(24):3884-9. PMID: 22085609.
      View in: PubMed
    56. Petrash JM, Ruzycki PA, Zablocki GJ. Guest editorial: visionary genomics. Hum Genomics. 2011 Oct; 5(6):519-21. PMID: 22155600.
      View in: PubMed
    57. Zablocki GJ, Ruzycki PA, Overturf MA, Palla S, Reddy GB, Petrash JM. Aldose reductase-mediated induction of epithelium-to-mesenchymal transition (EMT) in lens. Chem Biol Interact. 2011 May 30; 191(1-3):351-6. PMID: 21329682.
      View in: PubMed
    58. Ruiz FX, Moro A, Gallego O, Ard?vol A, Rovira C, Petrash JM, Par?s X, Farr?s J. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde. Chem Biol Interact. 2011 May 30; 191(1-3):199-205. PMID: 21329680.
      View in: PubMed
    59. Salabei JK, Li XP, Petrash JM, Bhatnagar A, Barski OA. Functional expression of novel human and murine AKR1B genes. Chem Biol Interact. 2011 May 30; 191(1-3):177-84. PMID: 21276782.
      View in: PubMed
    60. Hegde KR, Kowluru RA, Mohr S, Nagaraj RH, Petrash JM. New horizons in research on diabetic complications of the eye: special emphasis on diabetic cataracts and retinopathy. J Ophthalmol. 2010; 2010:979040. PMID: 21049002.
      View in: PubMed
    61. Srinivas P, Narahari A, Petrash JM, Swamy MJ, Reddy GB. Importance of eye lens a-crystallin heteropolymer with 3:1 aA to aB ratio: stability, aggregation, and modifications. IUBMB Life. 2010 Sep; 62(9):693-702. PMID: 20836128.
      View in: PubMed
    62. Huang SP, Palla S, Ruzycki P, Varma RA, Harter T, Reddy GB, Petrash JM. Aldo-keto reductases in the eye. J Ophthalmol. 2010; 2010:521204. PMID: 20628518.
      View in: PubMed
    63. Kahook MY, Liu L, Ruzycki P, Mandava N, Carpenter JF, Petrash JM, Ammar DA. High-molecular-weight aggregates in repackaged bevacizumab. Retina. 2010 Jun; 30(6):887-92. PMID: 20458261.
      View in: PubMed
    64. Muthenna P, Suryanarayana P, Gunda SK, Petrash JM, Reddy GB. Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance. FEBS Lett. 2009 Nov 19; 583(22):3637-42. PMID: 19850041.
      View in: PubMed
    65. Srivastava S, Vladykovskaya E, Barski OA, Spite M, Kaiserova K, Petrash JM, Chung SS, Hunt G, Dawn B, Bhatnagar A. Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice. Circ Res. 2009 Oct 09; 105(8):793-802. PMID: 19729598.
      View in: PubMed
    66. Bhagyalaxmi SG, Srinivas P, Barton KA, Kumar KR, Vidyavathi M, Petrash JM, Bhanuprakash Reddy G, Padma T. A novel mutation (F71L) in alphaA-crystallin with defective chaperone-like function associated with age-related cataract. Biochim Biophys Acta. 2009 Oct; 1792(10):974-81. PMID: 19595763.
      View in: PubMed
    67. Barton KA, Hsu CD, Petrash JM. Interactions between small heat shock protein alpha-crystallin and galectin-related interfiber protein (GRIFIN) in the ocular lens. Biochemistry. 2009 May 12; 48(18):3956-66. PMID: 19296714.
      View in: PubMed
    68. Shi Y, Barton K, De Maria A, Petrash JM, Shiels A, Bassnett S. The stratified syncytium of the vertebrate lens. J Cell Sci. 2009 May 15; 122(Pt 10):1607-15. PMID: 19401333.
      View in: PubMed
    69. Tammali R, Reddy AB, Ramana KV, Petrash JM, Srivastava SK. Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation. Carcinogenesis. 2009 May; 30(5):799-807. PMID: 19028703.
      View in: PubMed
    70. Reddy GB, Satyanarayana A, Balakrishna N, Ayyagari R, Padma M, Viswanath K, Petrash JM. Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy. Mol Vis. 2008 Mar 24; 14:593-601. PMID: 18385795.
      View in: PubMed
    71. Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac J Clin Nutr. 2008; 17(4):558-65. PMID: 19114390.
      View in: PubMed
    72. Chang Q, Petrash JM. Disruption of aldo-keto reductase genes leads to elevated markers of oxidative stress and inositol auxotrophy in Saccharomyces cerevisiae. Biochim Biophys Acta. 2008 Feb; 1783(2):237-45. PMID: 17919749.
      View in: PubMed
    73. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis. 2007 Jul 24; 13:1291-7. PMID: 17679931.
      View in: PubMed
    74. Spite M, Baba SP, Ahmed Y, Barski OA, Nijhawan K, Petrash JM, Bhatnagar A, Srivastava S. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem J. 2007 Jul 01; 405(1):95-105. PMID: 17381426.
      View in: PubMed
    75. Barton KA, Shui YB, Petrash JM, Beebe DC. Comment on: the Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmol Scand. 2007 May; 85(3):339-40. PMID: 17362364.
      View in: PubMed
    76. Estey T, Cantore M, Weston PA, Carpenter JF, Petrash JM, Vasiliou V. Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1. J Biol Chem. 2007 Feb 16; 282(7):4382-4392. PMID: 17158879.
      View in: PubMed
    77. Chang Q, Griest TA, Harter TM, Petrash JM. Functional studies of aldo-keto reductases in Saccharomyces cerevisiae. Biochim Biophys Acta. 2007 Mar; 1773(3):321-9. PMID: 17140678.
      View in: PubMed
    78. Singh R, White MA, Ramana KV, Petrash JM, Watowich SJ, Bhatnagar A, Srivastava SK. Structure of a glutathione conjugate bound to the active site of aldose reductase. Proteins. 2006 Jul 01; 64(1):101-10. PMID: 16639747.
      View in: PubMed
    79. Hsu CD, Kymes S, Petrash JM. A transgenic mouse model for human autosomal dominant cataract. Invest Ophthalmol Vis Sci. 2006 May; 47(5):2036-44. PMID: 16639013.
      View in: PubMed
    80. Petrash JM. All in the family: aldose reductase and closely related aldo-keto reductases. Cell Mol Life Sci. 2004 Apr; 61(7-8):737-49. PMID: 15094999.
      View in: PubMed
    81. Suryanarayana P, Kumar PA, Saraswat M, Petrash JM, Reddy GB. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis. 2004 Mar 12; 10:148-54. PMID: 15031705.
      View in: PubMed
    82. Chang Q, Harter TM, Rikimaru LT, Petrash JM. Aldo-keto reductases as modulators of stress response. Chem Biol Interact. 2003 Feb 01; 143-144:325-32. PMID: 12604219.
      View in: PubMed
    83. Rastelli G, Costantino L, Gamberini MC, Del Corso A, Mura U, Petrash JM, Ferrari AM, Pacchioni S. Binding of 1-benzopyran-4-one derivatives to aldose reductase: a free energy perturbation study. Bioorg Med Chem. 2002 May; 10(5):1427-36. PMID: 11886805.
      View in: PubMed
    84. Wu X, Chen SG, Petrash JM, Monnier VM. Alteration of substrate selectivity through mutation of two arginine residues in the binding site of amadoriase II from Aspergillus sp. Biochemistry. 2002 Apr 02; 41(13):4453-8. PMID: 11914093.
      View in: PubMed
    85. Cobb BA, Petrash JM. alpha-Crystallin chaperone-like activity and membrane binding in age-related cataracts. Biochemistry. 2002 Jan 15; 41(2):483-90. PMID: 11781086.
      View in: PubMed
    86. Petrash JM, Murthy BS, Young M, Morris K, Rikimaru L, Griest TA, Harter T. Functional genomic studies of aldo-keto reductases. Chem Biol Interact. 2001 Jan 30; 130-132(1-3):673-83. PMID: 11306085.
      View in: PubMed
    87. Ramana KV, Dixit BL, Srivastava S, Bhatnagar A, Balendiran GK, Watowich SJ, Petrash JM, Srivastava SK. Characterization of the glutathione binding site of aldose reductase. Chem Biol Interact. 2001 Jan 30; 130-132(1-3):537-48. PMID: 11306073.
      View in: PubMed
    88. Cobb BA, Petrash JM. Structural and functional changes in the alpha A-crystallin R116C mutant in hereditary cataracts. Biochemistry. 2000 Dec 26; 39(51):15791-8. PMID: 11123904.
      View in: PubMed
    89. Dixit BL, Balendiran GK, Watowich SJ, Srivastava S, Ramana KV, Petrash JM, Bhatnagar A, Srivastava SK. Kinetic and structural characterization of the glutathione-binding site of aldose reductase. J Biol Chem. 2000 Jul 14; 275(28):21587-95. PMID: 10764810.
      View in: PubMed
    90. Cobb BA, Petrash JM. Characterization of alpha-crystallin-plasma membrane binding. J Biol Chem. 2000 Mar 03; 275(9):6664-72. PMID: 10692476.
      View in: PubMed
    91. Reddy GB, Das KP, Petrash JM, Surewicz WK. Temperature-dependent chaperone activity and structural properties of human alphaA- and alphaB-crystallins. J Biol Chem. 2000 Feb 18; 275(7):4565-70. PMID: 10671481.
      View in: PubMed
    92. Das KP, Choo-Smith LP, Petrash JM, Surewicz WK. Insight into the secondary structure of non-native proteins bound to a molecular chaperone alpha-crystallin. An isotope-edited infrared spectroscopic study. J Biol Chem. 1999 Nov 19; 274(47):33209-12. PMID: 10559193.
      View in: PubMed
    93. Srivastava S, Watowich SJ, Petrash JM, Srivastava SK, Bhatnagar A. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry. 1999 Jan 05; 38(1):42-54. PMID: 9890881.
      View in: PubMed
    94. Petrash JM, Harter TM, Srivastava S, Chandra A, Bhatnagar A, Srivastava SK. Structure-function studies of FR-1. A growth factor-inducible aldo-keto reductase. Adv Exp Med Biol. 1999; 463:435-43. PMID: 10352716.
      View in: PubMed
    95. Srivastava SK, Chandra A, Srivastava S, Petrash JM, Bhatnagar A. Regulation of aldose reductase by aldehydes and nitric oxide. Adv Exp Med Biol. 1999; 463:501-7. PMID: 10352725.
      View in: PubMed
    96. Cecconi I, Moroni M, Vilardo PG, Dal Monte M, Borella P, Rastelli G, Costantino L, Garland D, Carper D, Petrash JM, Del Corso A, Mura U. Oxidative modification of aldose reductase induced by copper ion. Factors and conditions affecting the process. Biochemistry. 1998 Oct 06; 37(40):14167-74. PMID: 9760253.
      View in: PubMed
    97. Srivastava S, Harter TM, Chandra A, Bhatnagar A, Srivastava SK, Petrash JM. Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry. 1998 Sep 15; 37(37):12909-17. PMID: 9737870.
      View in: PubMed
    98. Chandra A, Srivastava S, Petrash JM, Bhatnagar A, Srivastava SK. Modification of aldose reductase by S-nitrosoglutathione. Biochemistry. 1997 Dec 16; 36(50):15801-9. PMID: 9398310.
      View in: PubMed
    99. Chandra A, Srivastava S, Petrash JM, Bhatnagar A, Srivastava SK. Active site modification of aldose reductase by nitric oxide donors. Biochim Biophys Acta. 1997 Sep 05; 1341(2):217-22. PMID: 9357961.
      View in: PubMed
    100. Petrash JM, Harter TM, Murdock GL. A potential role for aldose reductase in steroid metabolism. Adv Exp Med Biol. 1997; 414:465-73. PMID: 9059652.
      View in: PubMed
    101. Wilson DK, Nakano T, Petrash JM, Quiocho FA. Structural studies of aldo-keto reductase inhibition. Adv Exp Med Biol. 1997; 414:435-42. PMID: 9059648.
      View in: PubMed
    102. Cappiello M, Voltarelli M, Cecconi I, Vilardo PG, Dal Monte M, Marini I, Del Corso A, Wilson DK, Quiocho FA, Petrash JM, Mura U. Specifically targeted modification of human aldose reductase by physiological disulfides. J Biol Chem. 1996 Dec 27; 271(52):33539-44. PMID: 8969219.
      View in: PubMed
    103. Andley UP, Mathur S, Griest TA, Petrash JM. Cloning, expression, and chaperone-like activity of human alphaA-crystallin. J Biol Chem. 1996 Dec 13; 271(50):31973-80. PMID: 8943244.
      View in: PubMed
    104. Nakano T, Petrash JM. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase. Biochemistry. 1996 Aug 27; 35(34):11196-202. PMID: 8780524.
      View in: PubMed
    105. Das KP, Petrash JM, Surewicz WK. Conformational properties of substrate proteins bound to a molecular chaperone alpha-crystallin. J Biol Chem. 1996 May 03; 271(18):10449-52. PMID: 8631839.
      View in: PubMed
    106. Wilson DK, Nakano T, Petrash JM, Quiocho FA. 1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor. Biochemistry. 1995 Nov 07; 34(44):14323-30. PMID: 7578036.
      View in: PubMed
    107. Cook PN, Ward WH, Petrash JM, Mirrlees DJ, Sennitt CM, Carey F, Preston J, Brittain DR, Tuffin DP, Howe R. Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase. Biochem Pharmacol. 1995 Apr 18; 49(8):1043-9. PMID: 7748183.
      View in: PubMed
    108. Petrash JM, Tarle I, Wilson DK, Quiocho FA. Aldose reductase catalysis and crystallography. Insights from recent advances in enzyme structure and function. Diabetes. 1994 Aug; 43(8):955-9. PMID: 8039602.
      View in: PubMed
    109. Hay RE, Andley UP, Petrash JM. Expression of recombinant bovine gamma B-, gamma C- and gamma D-crystallins and correlation with native proteins. Exp Eye Res. 1994 May; 58(5):573-84. PMID: 7925695.
      View in: PubMed
    110. Tarle I, Borhani DW, Wilson DK, Quiocho FA, Petrash JM. Probing the active site of human aldose reductase. Site-directed mutagenesis of Asp-43, Tyr-48, Lys-77, and His-110. J Biol Chem. 1993 Dec 05; 268(34):25687-93. PMID: 8245005.
      View in: PubMed
    111. Wilson DK, Tarle I, Petrash JM, Quiocho FA. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc Natl Acad Sci U S A. 1993 Nov 01; 90(21):9847-51. PMID: 8234324.
      View in: PubMed
    112. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 1993 Feb; 42(2):221-32. PMID: 7678825.
      View in: PubMed
    113. Petrash JM, Harter T, Tarle I, Borhani D. Kinetic alteration of human aldose reductase by mutagenesis of cysteine residues. Adv Exp Med Biol. 1993; 328:289-300. PMID: 8493906.
      View in: PubMed
    114. Petrash JM, Harter TM, Devine CS, Olins PO, Bhatnagar A, Liu S, Srivastava SK. Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303. J Biol Chem. 1992 Dec 05; 267(34):24833-40. PMID: 1332968.
      View in: PubMed
    115. Borhani DW, Harter TM, Petrash JM. The crystal structure of the aldose reductase.NADPH binary complex. J Biol Chem. 1992 Dec 05; 267(34):24841-7. PMID: 1447221.
      View in: PubMed
    116. Bhatnagar A, Liu SQ, Petrash JM, Srivastava SK. Mechanism of inhibition of aldose reductase by menadione (vitamin K3). Mol Pharmacol. 1992 Nov; 42(5):917-21. PMID: 1435755.
      View in: PubMed
    117. Abghari SZ, Stulting RD, Petrash JM. Detection of herpes simplex virus type 1 latency-associated transcripts in corneal cells of inbred mice by in situ hybridization. Cornea. 1992 Sep; 11(5):433-8. PMID: 1330438.
      View in: PubMed
    118. Petrash JM, Flath M, Sens D, Bylander J. Effects of osmotic stress and hyperglycemia on aldose reductase gene expression in human renal proximal tubule cells. Biochem Biophys Res Commun. 1992 Aug 31; 187(1):201-8. PMID: 1520300.
      View in: PubMed
    119. Petrash JM. Applications of molecular biological techniques to the understanding of visual system disorders. Am J Ophthalmol. 1992 May 15; 113(5):573-82. PMID: 1575233.
      View in: PubMed
    120. el-Kabbani O, Narayana SV, Babu YS, Moore KM, Flynn TG, Petrash JM, Westbrook EM, DeLucas LJ, Bugg CE. Purification, crystallization and preliminary crystallographic analysis of porcine aldose reductase. J Mol Biol. 1991 Apr 20; 218(4):695-8. PMID: 1902521.
      View in: PubMed
    121. Petrash JM, DeLucas LJ, Bowling E, Egen N. Resolving isoforms of aldose reductase by preparative isoelectric focusing in the Rotofor. Electrophoresis. 1991 Jan; 12(1):84-90. PMID: 1904814.
      View in: PubMed
    122. Kaye NW, Lalley PA, Petrash JM, Church RL. Regional assignment of the mouse alpha A2-crystallin gene (Crya-1) to chromosome 17A3----B by in situ hybridization. Cytogenet Cell Genet. 1990; 53(2-3):95-6. PMID: 2369847.
      View in: PubMed
    123. Petrash JM, Favello AD. Isolation and characterization of cDNA clones encoding aldose reductase. Curr Eye Res. 1989 Oct; 8(10):1021-7. PMID: 2515032.
      View in: PubMed
    124. Hay RE, Petrash JM. Nucleotide sequence of a bovine lens alpha A-crystallin cDNA. Biochem Biophys Res Commun. 1987 Oct 14; 148(1):31-7. PMID: 3675580.
      View in: PubMed
    125. Hay RE, Woods WD, Church RL, Petrash JM. cDNA clones encoding bovine gamma-crystallins. Biochem Biophys Res Commun. 1987 Jul 15; 146(1):332-8. PMID: 3606621.
      View in: PubMed
    126. Kaye NW, Church RL, Piatigorsky J, Petrash JM, Lalley PA. Assignment of the mouse alpha A-crystallin structural gene to chromosome 17. Curr Eye Res. 1985 Dec; 4(12):1263-8. PMID: 4085253.
      View in: PubMed
    127. Srivastava SK, Das B, Hair GA, Gracy RW, Awasthi S, Ansari NH, Petrash JM. Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties. Biochim Biophys Acta. 1985 Jul 05; 840(3):334-43. PMID: 3924115.
      View in: PubMed
    128. Petrash JM, Srivastava SK. Purification and properties of human liver aldehyde reductases. Biochim Biophys Acta. 1982 Sep 22; 707(1):105-14. PMID: 6753936.
      View in: PubMed
    129. Srivastava SK, Ansari NH, Brown JH, Petrash JM. Formation of sorbitol 6-phosphate by bovine and human lens aldose reductase, sorbitol dehydrogenase and sorbitol kinase. Biochim Biophys Acta. 1982 Aug 06; 717(2):210-4. PMID: 6288113.
      View in: PubMed
    130. Srivastava SK, Petrash JM, Sadana IJ, Ansari NH, Partridge CA. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors. Curr Eye Res. 1982-1983; 2(6):407-10. PMID: 6820339.
      View in: PubMed
    Petrash's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (587) concept(s)
    _
    Co-Authors Expand Description
    See all (23) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)